To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Biglycan
Biglycan is a small leucine-rich repeat proteoglycan (SLRP) which is found in a variety of extracellular matrix tissues, including bone, cartilage and tendon. Additional recommended knowledge
CompositionIt consists of a protein core containing leucine-rich repeat regions and two glycosaminoglycan (GAG) chains consisting of either chondroitin sulfate (CS) or dermatan sulfate (DS), with DS being more abundant in most connective tissues. The CS/DS chains are attached at amino acids 5 and 10 in human biglycan.[1] The composition of the GAG chains has been reported as varying according to tissue of origin. Non-glycanated forms of biglycan (no GAG chains) increase with age in human articular cartilage.[2] NomenclatureThe name "biglycan" was proposed in an article by Fisher, Termine and Young in an article in the Journal of Biological Chemistry in 1989 because the proteoglycan contained two GAG chains; formerly it was known as proteoglycan-I (PG-I).[3] DiversityThe structure of biglycan core protein is highly conserved across species; over 90% homology has been reported for rat, mouse, bovine and human biglycan core proteins. InteractionsBiglycan interacts with collagen, both via the core protein and GAG chains [4] [5]. It has been reported that biglycan interacts more strongly with collagen type II than collagen type I [6] [7]. Biglycan has been reported to compete with decorin for the same binding site on collagen. [8] Similarity to decorinThe composition of GAG chains of biglycan and decorin originating from the same tissue has been reported to be similar [9]. FunctionBiglycan is believed to play a role in the mineralisation of bone. Knock-out mice that have had the gene for biglycan suppressed have an osteoporosis-like phenotype with reduced growth rate and lower bone mass than mice that can express biglycan.[10] Biglycan core protein binds to the growth factors BMP-4 and influences its bioactivity. [11] It has also been reported that the presence of biglycan is necessary for BMP-4 to exert its effects on osteoblasts [12]. There is also evidence that biglycan binds to TGF-beta 1 References
|
|||||||||||||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Biglycan". A list of authors is available in Wikipedia. |